Nantahala Capital Management, LLC
13F Reported Value
ⓘ$2.7B
incl. option notional
Equity Holdings
ⓘ$1.6B
Option Notional
ⓘ$1.1B
$613.4M puts / $500.7M calls
Holdings
152
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Nantahala Capital Management, LLC disclosed 152 positions worth $2.7B in its Form 13F-HR for Q1 2026 — $1.6B in common stock plus $1.1B of put/call option positions (reported at underlying notional value, not premium at risk), followed by $HLF and $PTON. During the quarter the fund opened 22 new positions and exited 23 — including a new stake in $QURE and a full exit from $EB. The portfolio is most concentrated in Healthcare (61.5% of disclosed assets). All figures are sourced directly from Nantahala Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1472322.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
ISHARES TR PUT
—Quality
$508.4M2,050,000 sh- —
Quality
$82.4M5,600,000 sh - 41.6#1,883
Quality
$77.0M17,938,900 sh - 32.8
Quality
$74.2M1,380,456 sh - 47.1
Quality
$67.5M5,000,000 sh - 67.6
Quality
$64.1M800,000 sh - 48.1
Quality
$59.2M1,513,656 sh - 46.3
Quality
$58.4M1,744,124 sh - 50.0
Quality
$55.9M6,122,403 sh - 41.6
Quality
$51.5M12,000,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| ISHARES TR PUT | — | $508.4M | 2,050,000 |
 HERBALIFE LTD.$HLFCALL | — | $82.4M | 5,600,000 |
 PELOTON INTERACTIVE, INC.$PTONCALL | 41.6#1,883 | $77.0M | 17,938,900 |
 Bancorp, Inc.$TBBK | 32.8 | $74.2M | 1,380,456 |
 Viatris Inc$VTRSCALL | 47.1 | $67.5M | 5,000,000 |
 Edwards Lifesciences Corp$EWPUT | 67.6 | $64.1M | 800,000 |
 Hilton Grand Vacations Inc.$HGV | 48.1 | $59.2M | 1,513,656 |
 SOLENO THERAPEUTICS INC$SLNO | 46.3 | $58.4M | 1,744,124 |
 Bioventus Inc.$BVS | 50.0 | $55.9M | 6,122,403 |
| PELOTON INTERACTIVE, INC.$PTON | 41.6 | $51.5M | 12,000,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Nantahala Capital Management, LLC's 152 positions.
Showing top 10 of 152 holdings.
Sector Allocation
Healthcare
$985.3M
Consumer Discretionary
$228.0M
Financials
$101.9M
Technology
$101.5M
Communication Services
$56.4M
Industrials
$39.8M
Consumer Staples
$27.9M
Materials
$24.4M
Full Holdings — Nantahala Capital Management, LLC (Q1 2026)
All 152 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | ISHARES TR | $508.4M | — | -24% | — |
| 2 | $HLFCALL | HERBALIFE LTD. | $82.4M | — | -28% | — |
| 3 | $PTONCALL | PELOTON INTERACTIVE, INC. | $77.0M | — | +176% | 41.6 |
| 4 | $TBBK | Bancorp, Inc. | $74.2M | 4.6% | +29% | 32.8 |
| 5 | $VTRSCALL | Viatris Inc | $67.5M | — | +0% | 47.1 |
| 6 | $EWPUT | Edwards Lifesciences Corp | $64.1M | — | -56% | 67.6 |
| 7 | $HGV | Hilton Grand Vacations Inc. | $59.2M | 3.7% | -3% | 48.1 |
| 8 | $SLNO | SOLENO THERAPEUTICS INC | $58.4M | 3.6% | +33% | 46.3 |
| 9 | $BVS | Bioventus Inc. | $55.9M | 3.5% | +1% | 50 |
| 10 | $PTON | PELOTON INTERACTIVE, INC. | $51.5M | 3.2% | +102% | 41.6 |
| 11 |  $ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $47.3M | 3.0% | -16% | 26.7 |
| 12 |  $TEVACALL | TEVA PHARMACEUTICAL INDUSTRIES LTD | $45.2M | — | -40% | — |
| 13 |  $QURECALL | uniQure N.V. | $42.5M | — | NEW | — |
| 14 | $HGVCALL | Hilton Grand Vacations Inc. | $42.1M | — | +0% | 48.1 |
| 15 |  $SVRA | Savara Inc | $40.1M | 2.5% | +0% | — |
| 16 | — | SPDR SERIES TRUST | $38.3M | — | -25% | — |
| 17 |  $XTNT | Xtant Medical Holdings, Inc. | $38.2M | 2.4% | +0% | 52.2 |
| 18 |  $GOGO | Gogo Inc. | $35.7M | 2.2% | +31% | 52.2 |
| 19 |  $AMRX | Amneal Pharmaceuticals, Inc. | $35.4M | 2.2% | +16% | 58.9 |
| 20 |  $REGNCALL | REGENERON PHARMACEUTICALS, INC. | $30.9M | — | +0% | 75.1 |
| 21 |  $AVR | Anteris Technologies Global Corp. | $30.7M | 1.9% | +119% | — |
| 22 |  $ETON | Eton Pharmaceuticals, Inc. | $29.0M | 1.8% | +0% | 51.9 |
| 23 |  $EOLS | Evolus, Inc. | $26.2M | 1.6% | +10% | 30 |
| 24 |  $TNGX | Tango Therapeutics, Inc. | $26.2M | 1.6% | -65% | 26.9 |
| 25 |  $LBRX | LB PHARMACEUTICALS INC | $26.0M | 1.6% | +56% | — |
| 26 | $SLNOCALL | SOLENO THERAPEUTICS INC | $25.1M | — | +49% | 46.3 |
| 27 |  $FOXF | FOX FACTORY HOLDING CORP | $24.5M | 1.5% | -32% | 33.8 |
| 28 |  $MLYS | Mineralys Therapeutics, Inc. | $24.3M | 1.5% | +690% | — |
| 29 |  $ZVRA | ZEVRA THERAPEUTICS, INC. | $23.5M | 1.5% | +42% | 65.6 |
| 30 |  $FULC | Fulcrum Therapeutics, Inc. | $23.4M | 1.5% | -29% | — |
| 31 |  $FOSL | Fossil Group, Inc. | $23.3M | 1.4% | +7% | 28.7 |
| 32 |  $RDNW | RideNow Group, Inc. | $23.1M | 1.4% | +0% | 31.2 |
| 33 |  $ABEO | ABEONA THERAPEUTICS INC. | $22.5M | 1.4% | +1% | 44.3 |
| 34 |  $CWH | Camping World Holdings, Inc. | $22.3M | 1.4% | +208% | 45.4 |
| 35 |  $ADCT | ADC Therapeutics SA | $21.0M | 1.3% | +2% | 16.3 |
| 36 |  $TITN | Titan Machinery Inc. | $21.0M | 1.3% | +3% | 38.4 |
| 37 | $HLF | HERBALIFE LTD. | $19.9M | 1.2% | +54% | — |
| 38 |  $IMAX | IMAX CORP | $19.6M | 1.2% | +8% | 53.9 |
| 39 |  $VSTM | Verastem, Inc. | $19.0M | 1.2% | +676% | 40.8 |
| 40 |  $BCRX | BIOCRYST PHARMACEUTICALS INC | $18.9M | 1.2% | +47% | 37.2 |
| 41 |  $AVTX | Avalo Therapeutics, Inc. | $18.4M | 1.1% | +0% | 4.6 |
| 42 |  $RMR | RMR GROUP INC. | $17.8M | 1.1% | +0% | 47.1 |
| 43 |  $RYAM | RAYONIER ADVANCED MATERIALS INC. | $17.7M | 1.1% | -11% | 31.1 |
| 44 |  $ALGNCALL | ALIGN TECHNOLOGY INC | $17.1M | — | +0% | 58.2 |
| 45 |  $GERN | GERON CORP | $16.7M | 1.0% | +24% | — |
| 46 |  $BNTC | Benitec Biopharma Inc. | $15.3M | 1.0% | +39% | — |
| 47 |  $ABVX | Abivax S.A. | $15.3M | 0.9% | -10% | — |
| 48 |  $ITGR | Integer Holdings Corp | $15.1M | 0.9% | +69% | 50.2 |
| 49 |  $KROS | Keros Therapeutics, Inc. | $15.0M | 0.9% | +277% | 57.2 |
| 50 |  $JACK | JACK IN THE BOX INC | $14.9M | 0.9% | +78% | 28 |
| 51 |  $JCAP | Jefferson Capital, Inc. / DE | $14.4M | 0.9% | +25% | 46.6 |
| 52 |  $AURA | Aura Biosciences, Inc. | $14.2M | 0.9% | +0% | — |
| 53 |  $USNA | USANA HEALTH SCIENCES INC | $14.2M | 0.9% | +38% | 40 |
| 54 |  $PCVX | Vaxcyte, Inc. | $13.9M | 0.9% | NEW | — |
| 55 | $CWHCALL | Camping World Holdings, Inc. | $13.7M | — | +0% | 45.4 |
| 56 |  $MDXG | MIMEDX GROUP, INC. | $13.4M | 0.8% | +41% | 55.6 |
| 57 |  $ASRT | Assertio Holdings, Inc. | $13.2M | 0.8% | +18% | 27.2 |
| 58 | $FOXFCALL | FOX FACTORY HOLDING CORP | $13.2M | — | NEW | 33.8 |
| 59 |  $DSGR | Distribution Solutions Group, Inc. | $13.0M | 0.8% | +50% | 53.1 |
| 60 |  $AGMB | Agomab Therapeutics NV | $12.9M | 0.8% | NEW | — |
| 61 | — | HELIX ACQUISITION CORP III | $12.7M | 0.8% | NEW | — |
| 62 |  $APYX | Apyx Medical Corp | $12.7M | 0.8% | -13% | 19.3 |
| 63 | $RDNWCALL | RideNow Group, Inc. | $12.0M | — | +0% | 31.2 |
| 64 |  $SLN | Silence Therapeutics plc | $11.3M | 0.7% | +39% | — |
| 65 |  $JANX | Janux Therapeutics, Inc. | $11.3M | 0.7% | NEW | 24.8 |
| 66 |  $CHYMCALL | Chime Financial, Inc. | $11.2M | — | +0% | 44.8 |
| 67 |  $GLUE | Monte Rosa Therapeutics, Inc. | $10.7M | 0.7% | +1024% | 18.1 |
| 68 |  $FLWS | 1 800 FLOWERS COM INC | $10.3M | 0.6% | +0% | 24.9 |
| 69 |  $CNTA | Centessa Pharmaceuticals plc | $10.1M | 0.6% | +0% | — |
| 70 |  $XFOR | X4 Pharmaceuticals, Inc | $10.1M | 0.6% | +0% | 29.3 |
| 71 |  $DUOL | Duolingo, Inc. | $9.9M | 0.6% | NEW | 82 |
| 72 |  $COGT | Cogent Biosciences, Inc. | $9.6M | 0.6% | +0% | — |
| 73 |  $SVC | Service Properties Trust | $9.6M | 0.6% | +0% | 35.7 |
| 74 |  $ILPT | Industrial Logistics Properties Trust | $9.5M | 0.6% | +0% | — |
| 75 |  $RSVR | Reservoir Media, Inc. | $9.2M | 0.6% | +0% | 54.6 |
| 76 |  $SLDB | Solid Biosciences Inc. | $8.4M | 0.5% | -27% | — |
| 77 |  $TLSI | TriSalus Life Sciences, Inc. | $8.3M | 0.5% | +0% | 28.3 |
| 78 |  $CRMT | AMERICAS CARMART INC | $8.2M | 0.5% | +0% | 40 |
| 79 |  $VMD | VIEMED HEALTHCARE, INC. | $8.1M | 0.5% | -5% | 57.2 |
| 80 |  $RH | RH | $8.1M | 0.5% | +53% | 53.2 |
| 81 |  $IRD | Opus Genetics, Inc. | $7.7M | 0.5% | -65% | — |
| 82 |  $KRRO | Korro Bio, Inc. | $7.5M | 0.5% | +10% | 5.8 |
| 83 |  $AMLX | Amylyx Pharmaceuticals, Inc. | $7.4M | 0.5% | -36% | — |
| 84 |  $DMRA | Damora Therapeutics, Inc. | $7.2M | 0.5% | NEW | — |
| 85 | $RHCALL | RH | $7.0M | — | +0% | 53.2 |
| 86 |  $LXEO | Lexeo Therapeutics, Inc. | $6.9M | 0.4% | +20% | — |
| 87 |  $VENU | Venu Holding Corp | $6.8M | 0.4% | NEW | 11.2 |
| 88 | $TBBKCALL | Bancorp, Inc. | $6.8M | — | NEW | 32.8 |
| 89 |  $CDXS | CODEXIS, INC. | $6.7M | 0.4% | +3% | 11.3 |
| 90 |  $DHX | DHI GROUP, INC. | $6.7M | 0.4% | +0% | 29.6 |
| 91 |  $UNCY | Unicycive Therapeutics, Inc. | $6.2M | 0.4% | +0% | — |
| 92 |  $GUTS | FRACTYL HEALTH, INC. | $6.1M | 0.4% | +23% | — |
| 93 |  $ALEC | Alector, Inc. | $6.1M | 0.4% | NEW | 8.9 |
| 94 |  $HAIN | HAIN CELESTIAL GROUP INC | $6.0M | 0.4% | +31% | 32.1 |
| 95 |  $DNTH | Dianthus Therapeutics, Inc. /DE/ | $5.6M | 0.3% | -82% | 26.8 |
| 96 |  $NSPR | InspireMD, Inc. | $5.5M | 0.3% | +0% | — |
| 97 |  $KOS | Kosmos Energy Ltd. | $5.1M | 0.3% | -21% | — |
| 98 |  $COCH | Envoy Medical, Inc. | $5.1M | 0.3% | NEW | — |
| 99 |  $ALTG | ALTA EQUIPMENT GROUP INC. | $5.0M | 0.3% | +0% | 34.6 |
| 100 |  $DRIO | DarioHealth Corp. | $4.9M | 0.3% | +8% | 18.9 |
| 101 |  $RVMD | Revolution Medicines, Inc. | $4.9M | 0.3% | NEW | — |
| 102 |  $NDLS | NOODLES & Co | $4.7M | 0.3% | -87% | 30.4 |
| 103 | $ABEOCALL | ABEONA THERAPEUTICS INC. | $4.6M | — | +96% | 44.3 |
| 104 |  $IKT | Inhibikase Therapeutics, Inc. | $4.5M | 0.3% | -31% | — |
| 105 |  $MARA | MARA Holdings, Inc. | $4.4M | 0.3% | +0% | 12.2 |
| 106 |  $CZR | Caesars Entertainment, Inc. | $4.0M | 0.3% | NEW | 44.3 |
| 107 |  $FORR | FORRESTER RESEARCH, INC. | $3.9M | 0.3% | NEW | 28.9 |
| 108 | $QURE | uniQure N.V. | $3.9M | 0.2% | -66% | — |
| 109 |  $STKS | ONE Group Hospitality, Inc. | $3.8M | 0.2% | +0% | 43.9 |
| 110 | $CHYM | Chime Financial, Inc. | $3.7M | 0.2% | NEW | 44.8 |
| 111 |  $UPB | Upstream Bio, Inc. | $3.6M | 0.2% | -19% | 22.6 |
| 112 |  $NNBR | NN INC | $3.5M | 0.2% | +0% | 25.8 |
| 113 |  $GRCE | Grace Therapeutics, Inc. | $3.4M | 0.2% | -38% | — |
| 114 |  $CGON | CG Oncology, Inc. | $3.3M | 0.2% | -55% | 28 |
| 115 |  $ELUT | ELUTIA INC. | $3.3M | 0.2% | +0% | — |
| 116 |  $XNCR | Xencor Inc | $3.2M | 0.2% | +61% | 13.1 |
| 117 |  $TELA | TELA Bio, Inc. | $3.2M | 0.2% | +1% | 24.9 |
| 118 |  $ARVN | ARVINAS, INC. | $3.2M | 0.2% | +0% | 13.9 |
| 119 |  $KIDS | ORTHOPEDIATRICS CORP | $3.2M | 0.2% | +0% | 33.4 |
| 120 |  $COOK | Traeger, Inc. | $3.0M | 0.2% | NEW | 23.8 |
| 121 |  $AYTU | AYTU BIOPHARMA, INC | $3.0M | 0.2% | +0% | 21.5 |
| 122 |  $SRL | Scully Royalty Ltd. | $2.9M | 0.2% | +0% | — |
| 123 |  $IMUX | IMMUNIC, INC. | $2.8M | 0.2% | -43% | — |
| 124 |  $AKBA | Akebia Therapeutics, Inc. | $2.8M | 0.2% | +0% | 46.4 |
| 125 |  $RLYB | Rallybio Corp | $2.7M | 0.2% | NEW | — |
| 126 |  $IRONPUT | Disc Medicine, Inc. | $2.6M | — | NEW | — |
| 127 |  $TLPH | TALPHERA, INC. | $2.6M | 0.2% | +0% | — |
| 128 |  $GAIA | GAIA, INC | $2.5M | 0.2% | +0% | 32.3 |
| 129 |  $PAYO | Payoneer Global Inc. | $2.3M | 0.1% | +0% | 55.3 |
| 130 |  $EHTH | eHealth, Inc. | $2.3M | 0.1% | +0% | 35.5 |
| 131 |  $RDI | READING INTERNATIONAL INC | $2.2M | 0.1% | +0% | 25.6 |
| 132 |  $DXLG | DESTINATION XL GROUP, INC. | $2.1M | 0.1% | -8% | 27 |
| 133 | $PCVXCALL | Vaxcyte, Inc. | $2.0M | — | +0% | — |
| 134 |  $BRCC | BRC Inc. | $2.0M | 0.1% | +0% | 32.3 |
| 135 |  $TRDA | Entrada Therapeutics, Inc. | $2.0M | 0.1% | NEW | 8.5 |
| 136 |  $ACHV | ACHIEVE LIFE SCIENCES, INC. | $1.9M | 0.1% | +0% | — |
| 137 | $IRON | Disc Medicine, Inc. | $1.6M | 0.1% | -81% | — |
| 138 |  $POCI | PRECISION OPTICS CORPORATION, INC. | $1.2M | 0.1% | NEW | — |
| 139 |  $PEPG | PepGen Inc. | $1.2M | 0.1% | -56% | — |
| 140 |  $VYNE | VYNE Therapeutics Inc. | $1.2M | 0.1% | +100% | — |
| 141 |  $CRIS | CURIS INC | $1.1M | 0.1% | NEW | — |
| 142 |  $PERF | Perfect Corp. | $986,833 | 0.1% | +0% | — |
| 143 |  $ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | $941,379 | 0.1% | +0% | — |
| 144 |  $ACU | ACME UNITED CORP | $917,377 | 0.1% | +0% | 44 |
| 145 |  $SNTI | Senti Biosciences Holdings, Inc. | $721,056 | 0.1% | +0% | — |
| 146 | $ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | $495,462 | 0.0% | +0% | — |
| 147 | $TELACALL | TELA Bio, Inc. | $465,000 | — | +0% | 24.9 |
| 148 |  $PHGE | BiomX Inc. | $430,940 | 0.0% | +0% | — |
| 149 |  $SGRP | SPAR Group, Inc. | $413,260 | 0.0% | +0% | 20.3 |
| 150 |  $APRE | Aprea Therapeutics, Inc. | $156,974 | 0.0% | +0% | — |
| 151 |  $GFAI | Guardforce AI Co., Ltd. | $9,252 | 0.0% | +0% | — |
| 152 | $PERF | Perfect Corp. | $238 | 0.0% | +0% | — |
New Positions (22)
$QURECALL uniQure N.V.$42.5M$PCVX Vaxcyte, Inc.$13.9M$FOXFCALL FOX FACTORY HOLDING CORP$13.2M$AGMB Agomab Therapeutics NV$12.9M$JANX Janux Therapeutics, Inc.$11.3M$DUOL Duolingo, Inc.$9.9M$DMRA Damora Therapeutics, Inc.$7.2M$VENU Venu Holding Corp$6.8M$TBBKCALL Bancorp, Inc.$6.8M$ALEC Alector, Inc.$6.1M$COCH Envoy Medical, Inc.$5.1M$RVMD Revolution Medicines, Inc.$4.9M$CZR Caesars Entertainment, Inc.$4.0M$FORR FORRESTER RESEARCH, INC.$3.9MExited Positions (23)
$EB Eventbrite, Inc.
$RAPT RAPT Therapeutics, Inc.
$GMED GLOBUS MEDICAL INC
$LYVPUT Live Nation Entertainment, Inc.
$GDEN NEW ROYAL HOLDCO I INC.
$CASH PATHWARD FINANCIAL, INC.
$QNCX Quince Therapeutics, Inc.
$CMCO COLUMBUS MCKINNON CORP
$SRZN Surrozen, Inc./DE$KROSCALL Keros Therapeutics, Inc.
$NKTR NEKTAR THERAPEUTICS
$NPCE NeuroPace Inc
$ANEB Anebulo Pharmaceuticals, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Nantahala Capital Management, LLC including:
Track Nantahala Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Nantahala Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Nantahala Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Nantahala Capital Management, LLC (SEC CIK: 1472322), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Nantahala Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.